ARCHIVES

NIH Reauthorization Threatened By Fetal Research Issue

This article is from The Cancer Letter archive.

Vol. 16 No. 38 | October 5, 1990

Download PDF Visit The Full Archive

Related Articles

Analysis Shows No Mortality Benefit From Regular PSA Screening

January 27, 2012

Center Directors To Rewrite 5-Year Plan With Little Staff Help

March 9, 1990

Reinventing NCI: Rimer Says Report Consistent with Her Goals For DCCPS

October 17, 1997

Avastin improves lung cancer survival, opens options for new combinations. Details of Avastin risk vs. benefit to be released at ASCO annual meeting.

April 1, 2005

NCI Study Find Farmers Using Herbicides At High Risk for Some Lymphomas

September 12, 1986

Seven New Initiatives For NIH Common Fund

February 26, 2010